FourThought Financial’s Abiomed Inc ABMD Stock Holding History

FourThought Financial’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$73K	Sell	298 -22	-7%	-$5.94K	0.01%	507
2022 Q2	$79K	Hold	320	–	–	0.01%	490
2022 Q1	$106K	Sell	320 -12	-4%	-$3.69K	0.01%	466
2021 Q4	$119K	Sell	332 -60	-15%	-$20.3K	0.02%	436
2021 Q3	$127K	Buy	392 +48	+14%	+$16.3K	0.02%	431
2021 Q2	$107K	Sell	344 -4	-1%	-$1.23K	0.01%	481
2021 Q1	$110K	Sell	348 -27	-7%	-$8.64K	0.02%	469
2020 Q4	$121K	Buy	+375	New	+$104K	0.02%	444

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

FourThought Financial's ABMD Position: Q3 2022 in Review

FourThought Financial reduced its Abiomed Inc (ABMD) stake by 6.9% in Q3 2022, selling an estimated $5.94K and leaving 298 shares worth $73K. The position accounts for 0.01% of the portfolio, ranked #507.

FourThought Financial first reported a position in ABMD in Q4 2020 and has held it in 8 quarters since. The position peaked at $127K in Q3 2021. 517 funds tracked by Wall St. Rank hold ABMD as of Q3 2022.

FourThought Financial held 298 shares of Abiomed Inc worth $73K as of Q3 2022.
FourThought Financial sold 22 Abiomed Inc shares in Q3 2022, an estimated $5.94K.
Abiomed Inc made up 0.01% of FourThought Financial's portfolio in Q3 2022, its #507 holding.
FourThought Financial first reported a position in Abiomed Inc in Q4 2020 and has held it in 8 quarters since.
FourThought Financial's Abiomed Inc position peaked at $127K in Q3 2021.
517 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2022.

Based on FourThought Financial's 13F filing for Q3 2022, filed 21 Nov 2022.